No Data
Stocks that moved the previous day, Part 2: Nitori HD, Metaplanet, Dental Medical, etc.
Stock name <code>26th closing price⇒Previous day comparison DMG Mori Seiki＜6141＞ 3315 -160 yen higher, believed to be greatly affected by the weak Euro. Yamaha Motor＜7272＞ 1217 -67.5, immediate supply and demand concerns due to the announcement of a major shareholder's sale. Nissan Motor Co＜7201＞ 422.9 -19, investment downgrade by JP Morgan Securities. Mazda Motor CRP＜7261＞ 1191.5, predominant selling pressure on automobile stocks due to the progress of the 41.5 yen rise. TOWA＜6315＞
Stocks that moved on the previous day, Part 1: Port, AmbiDX, Sapporo HD, etc.
Stock name <Code> 14th closing price ⇒ Previous day comparison Mabuchi Motor <6592> 2251.5 +119 Raised earnings and dividend estimates for the period ending December 2012. Also announced share buyback and retirement of up to 1.6% of issued shares. Tolidor HD <3397> 3506 -314 10.2% decrease in operating profit for the first quarter. HPC Systems <6597> 1137 +150 Expected increase of 40.9% in operating profit for the year ending June 2015. Mirai Works <6563> 838 +60 4.9% increase in operating profit for the period ending September 2014.
Stocks hitting the upper or lower price limit in the afternoon session.
Stop high <1841> Sunyu Construction <186A> Astro Scale Holdings <1914> Japan Foundation Technology <219A> Heartseed <2586> Flutter Flutter <3300> Ambition DX Holdings <3494> Marion <3540> Dental Medical <4386> SIG Group <4883> Modalis. Stop loss <2743> Pixel Companies <5618> Nile <6030> Adventure <7031>
Active and newly listed stocks during the morning session.
* Toho Zinc <5707> sees the first quarter earnings continued to be positive, with a rise of 131. * Sapporo HD <2501> profits improved by double digits during the June term. * Atlae <6194> fell due to the settlement, but the previous day's decline was also seen as an overreaction. * Sky Perfect JSAT <9412> is newly recommended for purchase by Iwai Cosmo Securities. * Lux <3923> exceeded market financial estimates in the first quarter operating revenue with a price rise of 155.
CI Medical: Extraordinary Report
CI Medical: Confirmation letter
No Data
No Data